Private Advisor Group LLC Boosts Stake in Sanofi (NASDAQ:SNY)

Private Advisor Group LLC boosted its holdings in shares of Sanofi (NASDAQ:SNY) by 6.1% in the 4th quarter, Holdings Channel reports. The fund owned 55,551 shares of the company’s stock after acquiring an additional 3,213 shares during the quarter. Private Advisor Group LLC’s holdings in Sanofi were worth $2,679,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. Synergy Asset Management LLC acquired a new position in shares of Sanofi during the 4th quarter worth approximately $25,000. McClarren Financial Advisors Inc. lifted its position in Sanofi by 952.6% during the fourth quarter. McClarren Financial Advisors Inc. now owns 600 shares of the company’s stock worth $28,000 after buying an additional 543 shares in the last quarter. Concord Wealth Partners boosted its stake in Sanofi by 157.8% during the third quarter. Concord Wealth Partners now owns 593 shares of the company’s stock worth $34,000 after buying an additional 363 shares during the last quarter. Fortitude Family Office LLC grew its holdings in Sanofi by 708.6% in the 3rd quarter. Fortitude Family Office LLC now owns 752 shares of the company’s stock valued at $43,000 after buying an additional 659 shares in the last quarter. Finally, Sunbelt Securities Inc. grew its holdings in Sanofi by 72.1% in the 3rd quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock valued at $43,000 after buying an additional 313 shares in the last quarter. Institutional investors and hedge funds own 14.04% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on SNY shares. StockNews.com cut shares of Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th. Sanford C. Bernstein upgraded shares of Sanofi to a “strong-buy” rating in a report on Thursday, January 30th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Sanofi from a “sell” rating to a “hold” rating in a report on Thursday, January 30th. Two equities research analysts have rated the stock with a hold rating, one has issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, Sanofi has an average rating of “Buy” and an average price target of $60.00.

Sanofi Stock Performance

NASDAQ SNY opened at $53.75 on Tuesday. The stock has a fifty day simple moving average of $51.10 and a 200-day simple moving average of $52.55. The company has a current ratio of 1.46, a quick ratio of 1.14 and a debt-to-equity ratio of 0.15. The stock has a market cap of $136.41 billion, a PE ratio of 21.59, a P/E/G ratio of 1.01 and a beta of 0.57. Sanofi has a twelve month low of $45.22 and a twelve month high of $58.97.

Sanofi (NASDAQ:SNY) last announced its earnings results on Thursday, January 30th. The company reported $0.70 earnings per share for the quarter, hitting the consensus estimate of $0.70. Sanofi had a net margin of 12.77% and a return on equity of 25.61%. Equities analysts anticipate that Sanofi will post 4.36 earnings per share for the current year.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.